Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > U.S. Health Chief Says No Evidence Linking Tylenol to Autism

U.S. Health Chief Says No Evidence Linking Tylenol to Autism

ECHEMI 2025-11-02

The U.S. Health Secretary stated that there is insufficient scientific evidence to support claims linking acetaminophen (Tylenol) use during pregnancy to autism, pushing back against a surge of lawsuits and public concern. The clarification follows online speculation and legal actions alleging that prenatal exposure to the common pain reliever increases autism risk in children. Federal health officials warned that misinformation may lead pregnant women to avoid medically necessary pain or fever treatment, which could pose greater danger to maternal and fetal health. The statement emphasised the need for evidence-based guidance and noted that ongoing research has not established causation. Regulators are monitoring emerging data but reiterated that current evidence does not justify changes to prescribing recommendations. The remarks aim to curb public alarm and reinforce reliance on scientifically validated medical advice.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.